Patent · US Active

Pharmaceutical composition containing combinations of nicotinamide and 5-aminosalicylic acid for beneficially influencing the intestinal microbiota and/or treating gastrointestinal inflammation

US10758552B2 · kind B2 · utility

0Cited by

1References

14Claims

0Family size

Assignee

CONARIS Research Institute AG · DE

Inventors

Georg H. Wätzig · Kiel, DE
Dirk Seegert · Dänischenhagen, DE

Key dates

Filing date	Dec 12, 2014
Grant date	Sep 1, 2020
Priority date	—
Expiry date	Dec 12, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/5047
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a new pharmaceutical composition containing a combination of 5-aminosalicylic acid and nicotinamide or related compounds. The combination is believed to beneficially influence the intestinal microbiota and/or reduce gastrointestinal inflammation. In certain embodiments, the pharmaceutical composition is partially or entirely released into the small intestine or large intestine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.